Navigation Links
Eclipsys to Present at JPMorgan Healthcare Conference
Date:12/27/2007

ATLANTA, Dec. 27 /PRNewswire-FirstCall/ -- Eclipsys Corporation(R) (Nasdaq: ECLP), The Outcomes Company(R), today announced it will be participating in the 2008 JPMorgan Healthcare Conference taking place from January 7th - 10th in San Francisco, CA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO )

Eclipsys executives will present at the conference on Tuesday, January 8th at 3:00 p.m. Pacific time. To access the live presentation via the web, interested parties can go to https://events.jpmorgan.com. The Eclipsys presentation can be accessed through the "Conference Webcasts" link for the JPMorgan Annual Healthcare Conference.

Listeners are encouraged to log on to the Web site approximately 10 minutes prior to the presentation start time to download the necessary software. A replay of the webcast will be archived in the Investor Relations area of the Eclipsys Web site following the presentation.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and access management software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and client satisfaction outcomes. For more information, see http://www.eclipsys.com or email info@eclipsys.com.

Management's prepared remarks and answers to questions during the presentation referenced in this release will include forward-looking statements, including concerning the company's sales, marketing and operational initiatives, future financial results, operating performance, development efforts, and the benefits provided by Eclipsys software and services. Actual results may differ from those projected due to a variety of risks and uncertainties. Future performance expectations are predicated upon achievement of various sales and performance targets that may be difficult to meet. Sales may be slower than expected due to market conditions, competition, and other factors. Costs may be greater than anticipated due to the potential need to increase spending to ensure performance in accordance with commitments to clients and other factors. Software development may take longer and cost more than expected, and incorporation of anticipated features and functionality may be delayed, due to various factors including programming and integration challenges and resource constraints. The market is highly competitive. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software, implementation or consulting services. The success and timeliness of the company's services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and clients can terminate contracts, assess penalties or reduce contract scope under certain circumstances. More information about company risks is available in recent Form 10-K and other filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation.

Eclipsys

Jason Cigarran Robert J. Colletti

Director, Investor Relations Chief Financial Officer (investors)

(561) 322-4355 (561) 322-4655

jason.cigarran@eclipsys.com investor.relations@eclipsys.com


'/>"/>
SOURCE Eclipsys Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
2. Eclipsys User Network Brings Eclipsys Clients Together to Share Outcome Improvement Strategies
3. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
4. Eclipsys Announces Relocation of Corporate Headquarters to Atlanta, GA
5. Eclipsys Sunrise Acute Care Receives CCHIT Certification
6. Eclipsys to Present at Piper Jaffray Healthcare Conference
7. Eclipsys to Present at the Merrill Lynch Health Services Investor Conference
8. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
9. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
10. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
11. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... The Association of Healthcare and Value ... their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will provide the ... value analysis professionals have a ‘seat at the table’ with clinical committees when ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently becoming ... require expert user knowledge. In a live webinar on April 11th and October ... highly accurate, determination of sodium. , It has long been known that too ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... ... overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the ... McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription ...
(Date:3/25/2017)... ... ... Getting earned media coverage meaningful for Garden Media Group's clients is the ... Garden Media aims to provide material helpful to clients’ goals and bottom lines. By ... messages to gain coveted media placements, Garden Media wows clients year-round. , Here ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
(Date:3/24/2017)... , March 24, 2017  Zymo ... company, and Hamilton Robotics, Inc., who designs, ... an ongoing collaboration that teams Zymo Research,s ... RNA and DNA extraction products with Hamilton,s ... created optimized methods for microbiomics and RNA ...
Breaking Medicine Technology: